TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 80 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2014. The put-call ratio across all filers is 5.00 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $739,000 | -54.6% | 6,558 | -54.9% | 0.00% | 0.0% |
Q2 2017 | $1,629,000 | +4.3% | 14,538 | +8.5% | 0.00% | 0.0% |
Q1 2017 | $1,562,000 | +61.7% | 13,394 | +46.0% | 0.00% | 0.0% |
Q4 2016 | $966,000 | +62.4% | 9,172 | +70.3% | 0.00% | 0.0% |
Q3 2016 | $595,000 | -21.3% | 5,385 | +3.8% | 0.00% | 0.0% |
Q2 2016 | $756,000 | -92.0% | 5,190 | -92.1% | 0.00% | -87.5% |
Q1 2016 | $9,453,000 | +104.0% | 65,991 | +120.1% | 0.01% | +100.0% |
Q4 2015 | $4,634,000 | +17.7% | 29,981 | +8.8% | 0.00% | +33.3% |
Q3 2015 | $3,938,000 | -0.6% | 27,560 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $3,960,000 | +1.9% | 27,560 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $3,887,000 | +25.5% | 27,560 | +31.9% | 0.00% | 0.0% |
Q4 2014 | $3,096,000 | +226.6% | 20,890 | +239.1% | 0.00% | +200.0% |
Q3 2014 | $948,000 | +13442.9% | 6,160 | +10340.7% | 0.00% | – |
Q1 2014 | $7,000 | +250.0% | 59 | +195.0% | 0.00% | – |
Q4 2013 | $2,000 | 0.0% | 20 | 0.0% | 0.00% | – |
Q3 2013 | $2,000 | – | 20 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |